Chimerix
financial strength supports development through key catalysts high probability of success for phase action study of low barriers to commercial potential for corporate capability and financial flexibility million in capital to fund operations as of june no debt fully funded program with multiple potential paths to approval in early dose studies at and early stage pipeline leverages external capital | Chimerix
Company
Deck date
August 2023
Slide
42 of 43
Similar slides by Chimerix
Investor Presentation
May 2023
Investor Presentation
March 2023
Related slides by other companies
Results
August 2020
Investor Presentation
March 2023
Results
August 2020
Results
August 2022
Other recent decks by Chimerix
Investor Presentation
May 2023
Investor Presentation
March 2023
Results
March 2022
Investor Conference
November 2021
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io